Table 2

Logistic regression analysis for the factors associated with the poor clinical course

Odds ratio (95% CI)P
Refractory status epilepticus (RSE) (n = 44, 29.9%)4.171 (1.656 to 10.503)0.002**
Age of onset ≥ 60 years (n = 34, 23.1%)4.110 (1.594 to 10.598)0.003**
Probable AE (ANPRA) subtype (n = 117, 79.6%)4.789 (1.411 to 16.254)0.012**
Infra-tentorium involvement in brain MRI (n = 19, 12.9%)10.225 (3.110 to 33.616)<0.001**
Delay of immunotherapy ≥ 1 month (n = 21, 14.3%)7.379 (2.383 to 22.843)0.001**
Odds ratio (95% CI)P
Refractory status epilepticus (RSE) (n = 44, 29.9%)4.171 (1.656 to 10.503)0.002**
Age of onset ≥ 60 years (n = 34, 23.1%)4.110 (1.594 to 10.598)0.003**
Probable AE (ANPRA) subtype (n = 117, 79.6%)4.789 (1.411 to 16.254)0.012**
Infra-tentorium involvement in brain MRI (n = 19, 12.9%)10.225 (3.110 to 33.616)<0.001**
Delay of immunotherapy ≥ 1 month (n = 21, 14.3%)7.379 (2.383 to 22.843)0.001**

R2 = 0.422 and P < 0.001 for the logistic regression equation.

**P < 0.01.

Table 2

Logistic regression analysis for the factors associated with the poor clinical course

Odds ratio (95% CI)P
Refractory status epilepticus (RSE) (n = 44, 29.9%)4.171 (1.656 to 10.503)0.002**
Age of onset ≥ 60 years (n = 34, 23.1%)4.110 (1.594 to 10.598)0.003**
Probable AE (ANPRA) subtype (n = 117, 79.6%)4.789 (1.411 to 16.254)0.012**
Infra-tentorium involvement in brain MRI (n = 19, 12.9%)10.225 (3.110 to 33.616)<0.001**
Delay of immunotherapy ≥ 1 month (n = 21, 14.3%)7.379 (2.383 to 22.843)0.001**
Odds ratio (95% CI)P
Refractory status epilepticus (RSE) (n = 44, 29.9%)4.171 (1.656 to 10.503)0.002**
Age of onset ≥ 60 years (n = 34, 23.1%)4.110 (1.594 to 10.598)0.003**
Probable AE (ANPRA) subtype (n = 117, 79.6%)4.789 (1.411 to 16.254)0.012**
Infra-tentorium involvement in brain MRI (n = 19, 12.9%)10.225 (3.110 to 33.616)<0.001**
Delay of immunotherapy ≥ 1 month (n = 21, 14.3%)7.379 (2.383 to 22.843)0.001**

R2 = 0.422 and P < 0.001 for the logistic regression equation.

**P < 0.01.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close